Alcon receives European approval for new trifocal presbyopia-correcting intraocular lens

1 min read

The FINANCIAL — Alcon, one of the global leaders in eye care and a division of Novartis, has received European CE Mark for its AcrySof IQ PanOptix trifocal intraocular lens (IOL) for patients undergoing cataract surgery who elect to address their near, intermediate, and distance vision needs with a single lens. The AcrySof IQ PanOptix trifocal IOL is an important addition to Alcon’s broad portfolio of intraocular lenses for cataract patients.

“The AcrySof IQ PanOptix trifocal IOL is a significant innovation which further augments Alcon’s presbyopia correcting portfolio, leveraging Alcon’s market-leading AcrySof IQ IOL platform,” said Franck Leveiller, Head of Research and Development for Alcon’s Surgical Franchise. “It is designed to provide exceptional functional vision from near to intermediate, in addition to providing excellent distance vision.”

More than three million cataract surgeries are performed each year in Europe. Without presbyopia-correcting IOLs, most patients undergoing cataract surgery experience compromised near vision often requiring additional vision correction following surgery such as reading glasses or contact lenses. The AcrySof IQ PanOptix trifocal IOL is indicated for adult patients with and without presbyopia undergoing cataract surgery who desire near, intermediate and distance vision with increased spectacle independence, according to Novartis.

“Today’s patients undergoing cataract surgery are more likely to seek vision correction options to address various lifestyle tasks such as reading books, using electronic tablets, working on computers and performing outdoor activities without the need for glasses or contact lenses,” said Richard Packard, MD, FRCS, FRCOphth, Director and senior ophthalmologist, Arnott Eye Associates, London, United Kingdom. “The AcrySof IQ PanOptix trifocal IOL is an important option that should provide these patients with a full range of vision and thus significantly reduced dependence on glasses.”

 

Leave a Reply